Replies to post #1198 on BioAdaptives Inc (BDPT)

[threewheeler]

thankx nice recap BDPT

[Ribo]

https://www.otcmarkets.com/stock/BDPT/news/story?e&id=2503333
https://www.otcmarkets.com/stock/BDPT/news/story?e&id=2500632
https://www.otcmarkets.com/stock/BDPT/news/story?e&id=2497130
https://www.otcmarkets.com/stock/BDPT/news/story?e&id=2497053
https://www.otcmarkets.com/stock/BDPT/news/story?e&id=2494783
https://www.otcmarkets.com/stock/BDPT/news/story?e&id=2492423
https://www.otcmarkets.com/stock/BDPT/news/story?e&id=2491478

[Truenorth2016]

BDPT Coveted $570,000,000 MILLION DOLLAR PATENT FOR .001?
"The company announced the intention to spin off its Livestock Impact Division as a wholly-owned subsidiary. Announced the Signing of a License for Eye Health due to Myopia and Presbyopia; a Patent Valued at US$ 570,000,000"

Wow, I dont think I ever saw this in OTC before....this is nothing to sleep on.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172123754

[DD_dempsey]

With $BDPT- Excllent DD post and with todays consolidation

I will look to solidify my position here before the next expected fundamental. There is so much to uncover here that I prefer not to compete with everyone for what’s left of the trips on this next retest of .0012 pps break eventually coming IMO.

I grabbed a starter toward end of day but will be doing my DD all night and tmrw and if I get what I want - I may stay awhile. This SS- with these parents and valuations - hard to deny the potential.

.0009 to .009+pps? Would love to see another 1000% move

[tabbycat]

Great DD

[janetcanada]

BDPT - Solid DD....Looking Forward with Expectation!....

[Truenorth2016]

WOW 2 Patents Signed For ...ALREADY SIGNED AND DONE!!!
Heck I just realize this myself!!! I dont think we noticed these two are DONE and already signed on a .001 cent stock this is crazy!!!....

1. Announced the Signing of a License for Eye Health due to Myopia and Presbyopia; a Patent Valued at US$ 570,000,000

2. Signs Non-Exclusive License With LY Research to Market Patented Product for Glucose Management a patent valued at Valued at US$210,000,000

[x-ray-eyes]

Excellent DD, next major runner, Audited Financials to boot, imo, $$$$

[Threeflight]

Interesting....

[AverageJoe]

Great post, powerbattles, this will fly!

[DD_dempsey]

$BDPT- DD on PATENTS …

CURRENTLY REVIEWING THE PATENT DD- READ BELOW : and it appears better then I initially thought. They are already licensing and product placing. But what I just discovered - is that they are also in process of purchasing those Patents for IP also. I’m trying to confirm if that have negotiated that out already. But that is massive IMO

RIGHTS TO USE- - 1- Additionally, the company acquired patent rights to a method to embed oxygen in water and is developing commercial products based on this technology that will augment and complement our current product lines.

RIGHT TO USE-
In February 2022, the Company acquired US Patent rights to a process that increases dissolved oxygen in water. The process produces MorO2, ingestion of which is believed to increase diffusion of oxygen into muscle tissues. The Company is developing a business plan to manufacture and market products based on the MorO2 technology.

ACQUIRE /OPTION to PURCHASE
2- Effective February 2, 2022, the Company acquired the option to purchase U.S. Patent No. 9,783,432B (the “Patent”), covering technology used in enhancing the capability of water to hold significantly larger amounts of oxygen. Since June 6, 2022, we entered into a services agreement with Wildpack Beverages in Las Vegas, Nevada to co-pack a pilot run (1333 cases) of this Product.

FROM THE 10K-

Effective February 2, 2022, the Company acquired the exclusive option to purchase U.S. Patent No. 9,783,432B (the “Patent”), covering technology used in enhancing the capability of water to hold significantly larger amounts of oxygen. The Agreement also allows the Company a two-year license to use the technology covered by the Patent, including for further development of oxygenated water products for consumers. The Agreement is more fully discussed in the Company’s Form 8-K filed on February 6, 2022. The Company intends to develop consumer products using the oxygenation technology, and has formed a wholly-owned subsidiary, MORO2, Inc. to conduct these activities.

AND NOW LETS LOOK AT THAT 8K - on the SEC EDGAR- $400k Option price!

Effective February 2, 2022, the Company entered into a Patent Purchase Agreement and Consulting Agreement with Thomas J. Mohr. Under the Agreement, the Company has the exclusive option to purchase Mohr’s U.S. Patent No. 9,783,432B (the “Patent”), which covers technology used in enhancing the capability of water to hold significantly larger amounts of oxygen, for a two-year period. The option price is $400,000

. The Agreement furthermore allows the Company a two-year license to use the technology covered by the Patent, including for further development of oxygenated water products for consumers. In exchange for the license, the Company will pay Mohr a royalty, scaled to total product sales.

The Agreement also calls for Mohr to provide consultant/inventor services to the Company during the option period, which may include establishing a research laboratory and prototype manufacturing facility. Among other things, Mohr will assist the Company in developing additional consumer products using the oxygenation technology and provide technical services for manufacture, installation, and use of production machinery. Mohr will be paid a monthly cash stipend. In addition, Mohr allows the Company rights as to inventions created during the Agreement.

The Company will exploit the Patent and Mohr’s consulting services through a newly established wholly-owned subsidiary, MORO2, Inc.

READ THE 8K and PATENT PURCHASE AGREEMENT HERE :
https://www.otcmarkets.com/filing/html?id=15529463&guid=WZT-kWlPRuohOrh


The patents info:
https://patents.justia.com/inventor/yaguang-liu

THAT IS VERY INTRIGUING and I’m currently in process of confirming the later OPTION TO PURCHASE THE PATENT. Imo- that increases the valuation here substantially. But First we need Confirmation.

[KeepItRealistic]

They also have 2 recent patents with an estimated value of over $780 million. (Patent # US 9,622,970 B2 ) for Eye Health due to Myopia and Presbyopia is valued at US$570,000,000 by Grant Thornton.” (Patent # us 8,114,444 B2 ) for glucose management. The patent has a valuation of US$210/m as valued by Grant Thornton Accounting Firm.


Trading at a Market Cap of 750k !

[JusDePomme]

Unreal slow day!!

[JusDePomme]

Ban oi ...vfs ra co phieu! Xe vinfas nhinh dep sao Kong ai mua?

[Max2121]

Very positive news.

[tchalla]

roflmao. why isn't that asset listed on their balance sheet. stop misleading people here. truly misleading.

[Digby1]

Not a big deal, but you're pic of David Allen is not the right guy.

https://www.botanicaldrug.org/

Scroll down to leadership team to see the real David Allen.
Lots of other interesting people on this team as well, btw.

[knrorrel]

So, the people who don't buy now with these cheap PPS - it's their own fault...... and missing out on profits on this long-term gem
imho